✦ LIBER ✦

Transplantation of allogeneic CD34+-selected cells followed by early T-cell add-backs: favorable results in acute and chronic myeloid leukemia

✍ Scribed by Kobbe, G.; Fenk, R.; Neumann, F.; Bernhardt, A.; Steidl, U.; Kondakci, M.; Graef, T.; Aivado, M.; Vaupel, M.; Huenerlituerkoglu, A.-N.; Kronenwett, R.; Pape, H.; Hildebrand, B.; Germing, U.; Haas, R.

Book ID: 122169186
Publisher: Informa plc
Year: 2004
Tongue: English
Weight: 225 KB
Volume: 6
Category: Article
ISSN: 1465-3249
DOI: 10.1080/14653240410005375

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mixed chimerism is frequent after alloge

Mixed chimerism is frequent after allogeneic peripheral blood stem cell transplantation with positive CD34 selection, and is not reverted by low doses of donor T-cells add-back

✍ Marta Rodríguez-Luaces; Christelle Ferrá; Gregorio Martín-Henao; Juan José Berla 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB

Comparative Effectiveness Analysis Of CD

Comparative Effectiveness Analysis Of CD34 + Selected, T-Cell Depleted (TCD) HLA-Matched Sibling Grafts On Allogeneic Hematopoietic Cell Transplantation For Patients With Acute Myeloid Leukemia (AML) In Complete Remission

✍ M.C. Pasquini; S. Devine; A. Mendizabal; L.R. Baden; J.R. Wingard; H.M. Lazarus; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Comparative Outcomes of Donor Graft CD34

Comparative Outcomes of Donor Graft CD34+ Selection and Immune Suppressive Therapy As Graft-Versus-Host Disease Prophylaxis for Patients With Acute Myeloid Leukemia in Complete Remission Undergoing HLA-Matched Sibling Allogeneic Hematopoietic Cell Transplantation

✍ Pasquini, M. C.; Devine, S.; Mendizabal, A.; Baden, L. R.; Wingard, J. R.; Lazar 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 162 KB

Lymphodepletion is permissive to the dev

Lymphodepletion is permissive to the development of spontaneous T-cell responses to the self-antigen PR1 early after allogeneic stem cell transplantation and in patients with acute myeloid leukemia undergoing WT1 peptide vaccination following chemotherapy

✍ Katayoun Rezvani, Agnes S. M. Yong, Stephan Mielke, Bipin N. Savani, Behnam Jafa 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 593 KB

202: Preliminary Results of a Phase I St

202: Preliminary Results of a Phase I Study of Immuno-Chemotherapy (CTX) Conditioning with Gemtuzumab Ozogamicin (GO), Busulfan (Bu) and Cyclophosphamide (Cy) Followed by Allogeneic Stem Cell Transplantation (AlloSCT) in Pediatric Recipients with High Risk (HR) CD33+ Acute Myelogenous Leukemia (AML)

✍ I. Waxman; M. Bhatia; E. Qualter; Z.Z. Jin; V. Kohl; L. Baldinger; J. Guerra; J. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 59 KB